Clinical Trial

Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.

Study acronym: LACTMET
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.
Trial Details
NCT Number NCT07426172
Lead Sponsor Ricardo Mora
Collaborators: University of Castilla-La Mancha
Conditions Hyperlactatemia, Metabolic Syndrome (MetS), Lipolysis, Exercise
Enrollment 24 participants
Start Date 2026-01-20
Primary Completion 2028-01-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-23